Ophir Asset Management’s Astrana Health ASTH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-140,845
Closed -$5.49M 37
2022
Q3
$5.49M Sell
140,845
-26,001
-16% -$1.19M 1% 28
2022
Q2
$30.2M Sell
166,846
-130,751
-44% -$4.97M 6.2% 3
2022
Q1
$14.4M Buy
+297,597
New +$15.4M 2.22% 17
2021
Q4
Sell
-87,839
Closed -$8M 41
2021
Q3
$8M Sell
87,839
-86,151
-50% -$7.33M 1.11% 30
2021
Q2
$10.9M Sell
173,990
-244,291
-58% -$9.03M 1.92% 21
2021
Q1
$11.2M Buy
+418,281
New +$10.1M 2.26% 18

Other funds holding ASTH

Ophir Asset Management's ASTH Position: Q4 2022 in Review

Ophir Asset Management sold out of Astrana Health (ASTH) in Q4 2022, closing a stake of 140,845 shares — an estimated $5.49M sold.

Ophir Asset Management first reported a position in ASTH in Q1 2021 and held it in 6 quarters. The position peaked at $30.2M in Q2 2022. 130 funds tracked by Wall St. Rank hold ASTH as of Q4 2022.

  • Ophir Asset Management reported no remaining Astrana Health position as of Q4 2022 after selling out during the quarter.
  • Ophir Asset Management sold 140,845 Astrana Health shares in Q4 2022, an estimated $5.49M.
  • Ophir Asset Management first reported a position in Astrana Health in Q1 2021 and held it in 6 quarters.
  • Ophir Asset Management's Astrana Health position peaked at $30.2M in Q2 2022.
  • 130 funds tracked by Wall St. Rank held Astrana Health as of Q4 2022.

Based on Ophir Asset Management's 13F filing for Q4 2022, filed 14 Feb 2023.